Amgen logo

Medical Science Liaison, U.S. Medical, Rare Disease-GPA/MPA & Sjögren’s Disease (NC/SC/VA)

Amgen

Charlotte, NC; Raleigh, NC; Charleston, SC; Columbia, SCOnsitePosted 19 days ago$156,998.40 - $212,409.60/year
Full TimeSenior LevelMedical AffairsPharmaceutical
Original posting ↗

Summary

The Medical Science Liaison (MSL) acts as the primary scientific/clinical resource to Opinion Leaders (OLs), Population Health Decision Makers (PHDMs) and other health care providers and is responsible for executing Amgen Medical function and product strategy as led by MSL Leadership, with the goal of giving accurate information to OLs, community healthcare providers and PHDMs to improve patient outcomes.

Job description

The Rare Disease-GPA/MPA & Sjogren’s Disease MSL is a field-based position within the U.S. Medical team reporting to the Rare Disease-GPA/MPA & Sjogren’s Disease MSL Field Director.

Strategic Execution

  • Majority of time spent on peer-to-peer activities with Rare Disease-GPA/MPA and Sjogren’s Disease Opinion Leaders, community healthcare providers, and PHDMs to discuss and advance the scientific platform as aligned with Amgen’s corporate goals and objectives.
  • Engage with PHDMs within assigned IDNs and other institutions to communicate scientific based data of clinical value, outcomes, and economic data.
  • Connect external and internal stakeholders to amplify Amgen’s reach and access for patients.
  • Conduct in-depth scientific exchange to provide focused and balanced clinical and scientific information consistent with MSL compliance standards.
  • Support Amgen sponsored research.
  • Liaise with potential investigators in non-sponsored clinical research.
  • Provide field observations and insights to internal stakeholders to inform Amgen strategies.
  • Support congress activities as aligned with strategy.
  • Support speaker training as requested and ensure the speakers are updated on new data.
  • Participate on project teams that support MSL strategies and tactics as delegated by MSL leadership.

Cross Functional Collaboration

  • Compliantly partner across all Amgen field roles who share customers to create an appropriately coordinated One Amgen experience.

Core Competencies

  • MSLs instill passion and move HCPs to take action in improving patient care related to closing care gaps.
  • Execute all administrative responsibilities and training (e.g., Veeva CRM, expense reports, compliance modules, etc.) in a timely manner.
  • Maintain and improve clinical/scientific acumen and expertise with current data/information and healthcare trends.
  • Ability to build and maintain strong relationships with external stakeholders, and possess excellent communication skills to effectively communicate scientific data.

Requirements

  • Doctorate degree
  • Master’s degree & 3 years of Medical Affairs experience
  • Bachelor’s degree & 5 years of Medical Affairs experience
  • Pharm.D., Ph.D., M.D. or D.O. (other doctoral degrees considered)
  • Five or more years in a medically related field, including 1 year focused on clinical practice, clinical research, or medical research
  • Rare Disease-GPA/MPA and/or Sjögren’s Disease expertise

Benefits

  • 401(k) Matching
  • Medical, Dental & Vision
  • Life & Disability Insurance
  • Flexible Spending Accounts
  • Annual Bonus
  • Stock-based Long-term Incentives
  • Paid Time Off
  • Flexible Work Models

Company overview

Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.